These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8614452)

  • 21. Vaccines. Monkey puzzles.
    Cohen J
    Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
    [No Abstract]   [Full Text] [Related]  

  • 22. Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.
    Schooley RT; Spino C; Kuritzkes D; Walker BD; Valentine FA; Hirsch MS; Cooney E; Friedland G; Kundu S; Merigan TC; McElrath MJ; Collier A; Plaeger S; Mitsuyasu R; Kahn J; Haslett P; Uherova P; deGruttola V; Chiu S; Zhang B; Jones G; Bell D; Ketter N; Twadell T; Chernoff D; Rosandich M
    J Infect Dis; 2000 Nov; 182(5):1357-64. PubMed ID: 11023459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C; Xu JQ
    Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
    [No Abstract]   [Full Text] [Related]  

  • 24. Preparation for HIV vaccine efficacy trials.
    Hoff R; Lawrence DN
    Antibiot Chemother (1971); 1996; 48():155-60. PubMed ID: 8726520
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of an oral therapeutic HIV-1 vaccine on AIDS patients with CD4 count above 250 cells/mm3.
    Jirathitikal V; Bourinbaiar AS
    Acta Virol; 2004; 48(2):73-8. PubMed ID: 15462281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged survival of end-stage AIDS patients immunized with therapeutic HIV vaccine V-1 Immunitor.
    Metadilogkul O; Jirathitikal V; Bourinbaiar AS
    Biomed Pharmacother; 2005 Sep; 59(8):469-73. PubMed ID: 16126364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recent topics on AIDS research-- study of AIDS viruses and the application for development of prevention and therapeutic methods of AIDS].
    Honda M
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):606-7. PubMed ID: 8963762
    [No Abstract]   [Full Text] [Related]  

  • 28. Army expected to clear AIDS scientist.
    Science; 1993 Jul; 261(5117):19. PubMed ID: 8316847
    [No Abstract]   [Full Text] [Related]  

  • 29. Army clears Redfield--but fails to resolve controversy.
    Cohen J
    Science; 1993 Aug; 261(5123):824-5. PubMed ID: 8346432
    [No Abstract]   [Full Text] [Related]  

  • 30. First AIDS vaccine trial launched.
    Science; 1998 Jun; 280(5370):1697. PubMed ID: 9660708
    [No Abstract]   [Full Text] [Related]  

  • 31. Candidate vaccines protect macaques against primate immunodeficiency viruses.
    Stott J; Hu SL; Almond N
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of HIV-infections: success or crisis?].
    Pokrovskiĭ VV
    Ter Arkh; 2001; 73(11):52-4. PubMed ID: 11806206
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on vaccine development in AIDS and cancer.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1995 Apr; 1(3):18-24. PubMed ID: 11362485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AIDS vaccine: efficacy, safety and ethics.
    Veljkovic V; Veljkovic N; Glisic S; Ho MW
    Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.
    Birx DL; Loomis-Price LD; Aronson N; Brundage J; Davis C; Deyton L; Garner R; Gordin F; Henry D; Holloway W; Kerkering T; Luskin-Hawk R; McNeil J; Michael N; Foster Pierce P; Poretz D; Ratto-Kim S; Renzullo P; Ruiz N; Sitz K; Smith G; Tacket C; Thompson M; Tramont E; Yangco B; Yarrish R; Redfield RR
    J Infect Dis; 2000 Mar; 181(3):881-9. PubMed ID: 10720508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Merck's HIV vaccine flop brings vectors under closer scrutiny.
    Ledford H
    Nat Biotechnol; 2008 Jan; 26(1):3-4. PubMed ID: 18182999
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vaccination; not for tomorrow, but...].
    Taéron C
    Rev Infirm; 2002 Mar; (79):25. PubMed ID: 11979669
    [No Abstract]   [Full Text] [Related]  

  • 38. Cold shower for AIDS vaccines.
    Nat Med; 2007 Dec; 13(12):1389-90. PubMed ID: 18064013
    [No Abstract]   [Full Text] [Related]  

  • 39. African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent.
    Kaleebu P; Abimiku A; El-Halabi S; Koulla-Shiro S; Mamotte N; Mboup S; Mugerwa R; Nkengasong J; Toure-Kane C; Tucker T; Wassenaar D; Williamson C; Wolday D
    PLoS Med; 2008 Dec; 5(12):e236. PubMed ID: 19053171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 25 years of HIV research! ... and what about a vaccine?
    Appay V
    Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.